TRPM2 and cancer: In gastric cancer, inhibition of TRPM2 has been shown to increase the efficacy of doxorubicin and paclitaxel (Almasi et al., 2018), a widely used anticancer drug in cancer therapy (Mekhail and Markman, 2002).